California Public Employees Retirement System’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-25,000
Closed -$971K – 2758
2021
Q1
$971K Hold
25,000
– – ﹤0.01% 2523
2020
Q4
$1.55M Sell
25,000
-500
-2% -$22.9K ﹤0.01% 2169
2020
Q3
$854K Buy
25,500
+800
+3% +$22.8K ﹤0.01% 2390
2020
Q2
$589K Buy
24,700
+10,230
+71% +$243K ﹤0.01% 2584
2020
Q1
$331K Hold
14,470
– – ﹤0.01% 2608
2019
Q4
$410K Buy
+14,470
New +$364K ﹤0.01% 2820

Other funds holding STOK

California Public Employees Retirement System's STOK Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Stoke Therapeutics (STOK) in Q2 2021, closing a stake of 25,000 shares — an estimated $971K sold.

California Public Employees Retirement System first reported a position in STOK in Q4 2019 and held it in 6 quarters. The position peaked at $1.55M in Q4 2020. 97 funds tracked by Wall St. Rank hold STOK as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Stoke Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 25,000 Stoke Therapeutics shares in Q2 2021, an estimated $971K.
  • California Public Employees Retirement System first reported a position in Stoke Therapeutics in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Stoke Therapeutics position peaked at $1.55M in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.